Pictet Asset Management Holding Sa Avidity Biosciences, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 786,480 shares of RNA stock, worth $25.9 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
786,480
Previous 379,802
107.08%
Holding current value
$25.9 Million
Previous $15.5 Million
132.84%
% of portfolio
0.04%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
250Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$350 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$304 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$284 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$268 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$232 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.72B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...